WellSpan Heart and Vascular is pioneering clinical innovation by integrating advanced technologies into their diagnostic and treatment protocols. This initiative is enhancing care quality for patients, with several notable advancements:
- 4D CT Technology: WellSpan’s lab is the first in the nation to adopt 4D CT technology, which aids in detecting heart issues more effectively at earlier stages.
- Pulse Field Ablation: This technique is utilized for treating atrial fibrillation, characterized by an unusually rapid heart rate, improving patient outcomes.
- Dual-Chamber Leadless Pacemakers: These compact devices are implanted directly into the heart, avoiding the need for traditional cardiac leads, thereby streamlining the procedure and recovery process.
- AGENT Drug-Coated Balloon: WellSpan is the inaugural user in Pennsylvania of this innovative treatment for coronary artery disease, offering a new option for patient care.
Further details on these technological advancements are available in WellSpan’s recently released Community Impact Report, accessible here.
Photo credits to WellSpan Health
